(S)-6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine, 95.0%, 100mg

(1R,2R,3R,4S,5S,6S,7R,8S)-Methyl 4-cyanocubane-1-carboxylate, 98%, 100mg

1-[4-(3-fluorophenyl)tetrahydro-2H-pyran-4-yl]methanamine, 95.0%, 250mg

4-(2-(tert-Butoxycarbonyl)hydrazinyl)benzoic acid, 95.0%, 10g

tert-Butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate, 95.0%, 10g

2-(3,5-Dinitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)1g

Ethyl 5-methoxy-2-methyl-1H-indole-3-carboxylate, 97%, 1g

Cyclohexane, min. 99.5%, for synthesis, 25 l, white blister

3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

5-(HEPTAN-3-YL)IMIDAZOLIDINE-2,4-DIONE, 95.0%, 1g

N2-Methylpyridine-2,4-diamine hydrochloride, 95.0%, 5g

4-(Tert-butoxymethyl)benzoic acid, 95+%, 5g

(5-Fluoro-2-formylphenyl)boronic acid, 95.0%, 1g